CCL5 was a chemokine involved in immune regulation and inflammation [41], and its mRNA expression was significantly related to immune activation and pathologic complete response increase of neoadjuvant chemotherapy in breast cancer (P < 0.001, OR = 1.41[1.23–1.62]) [42]. The gene discussed is CCL5; the disease is breast carcinoma.